BI
NVO

Bramshill Investments’s Novo Nordisk NVO Stock Holding History

Bramshill Investments’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-308
Closed -$7K – 159
2018
Q4 		$7K Sell
308
-86
-22% -$1.91K ﹤0.01% 177
2018
Q3 		$9K Buy
+394
New +$9.62K ﹤0.01% 182

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Bramshill Investments's NVO Position: Q1 2019 in Review

Bramshill Investments sold out of Novo Nordisk (NVO) in Q1 2019, closing a stake of 308 shares — an estimated $7K sold.

Bramshill Investments first reported a position in NVO in Q3 2018 and held it in 2 quarters. The position peaked at $9K in Q3 2018. 580 funds tracked by Wall St. Rank hold NVO as of Q1 2019.

  • Bramshill Investments reported no remaining Novo Nordisk position as of Q1 2019 after selling out during the quarter.
  • Bramshill Investments sold 308 Novo Nordisk shares in Q1 2019, an estimated $7K.
  • Bramshill Investments first reported a position in Novo Nordisk in Q3 2018 and held it in 2 quarters.
  • Bramshill Investments's Novo Nordisk position peaked at $9K in Q3 2018.
  • 580 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2019.

Based on Bramshill Investments's 13F filing for Q1 2019, filed 15 May 2019.